SCHEMBL19080062

SCHEMBL19080062

c1ccc2cc3c(cc2c1)oc1cc(-c2ccc4cc(-c5c6ccccc6c(-c6cccc7ccccc67)c6ccccc56)ccc4c2)c2ccccc2c13

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSD A5PKW4 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
ALDH1A1 P00352 2/20 0.34
PIM1 P11309 2/20 0.34
GPR84 Q9NQS5 1/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34
RAB9A P51151 1/20 0.34
ATM Q13315 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MCL1 Q07820 1/20 0.33
ACMSD Q8TDX5 1/20 0.33
PRKDC P78527 1/20 0.33
MAPT P10636 1/20 0.33
SOS1 Q07889 1/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18810730 0.92 PSD (0.36) PSDALDH1A1KDM4ECYP1A2CYP2C19
SCHEMBL19076464 0.92 ALOX5 (0.36) PSDHDAC4HDAC2HDAC8ALDH1A1
SCHEMBL17943910 0.91 TDP1 (0.38) HDAC4HDAC2HDAC8ALDH1A1PIM1
SCHEMBL19080096 0.91 GSTP1 (0.40) HDAC4HDAC2HDAC8ALDH1A1GPR84
SCHEMBL19076478 0.91 ALOX5 (0.36) PSDHDAC4HDAC2HDAC8ALDH1A1
SCHEMBL19080070 0.90 ABCG2 (0.37) PSDALDH1A1CYP1A2CYP2C19RAB9A
SCHEMBL19080064 0.90 ABCG2 (0.38) HDAC4HDAC2HDAC8ALDH1A1GPR84
SCHEMBL19080033 0.88 ESR1 (0.40) HDAC4HDAC2HDAC8ALDH1A1GPR84
SCHEMBL19080056 0.88 ABCG2 (0.37) PSDALDH1A1CYP1A2CYP2C19RAB9A
SCHEMBL19080080 0.87 GPR84 (0.35) HDAC4HDAC2HDAC8ALDH1A1PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 PSD 3401/4885HDAC4 2799/4885HDAC2 727/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 PSD 3401/4885HDAC4 2799/4885HDAC2 727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.